Company
PROCEPT BioRobotics
Summary
- Redwood City, United States
- Stage: Startup
- Use: Civil
- Focus: Hardware-first
Fields
About
Makes robotic systems for Aquablation therapy, a waterjet treatment for benign prostatic hyperplasia (BPH).
Funding
- Total raised
- $637.7M
- Newest round
- Liquidation · $150M1 Aug 2023
| Investor | Rounds |
|---|---|
| Physicians Management Group | Series D, Series E, Series G |
| Viking Global Investors | Series ELead, Series G |
| Perceptive Advisors | Series E, Series G |
| Novo Capital | Series DLead |
| Novo Holdings | Series DLead |
| Armentum Partners | Debt Refin. |
| Fidelity Investments | Series GLead |
| T. Rowe Price | Series G |
| Duquesne Family Office LLC | Series G |
| CIBC Innovation Banking | Debt - PPPLead |
Aviato · checked 12 Oct 2026
Machines
2Medical and surgical
AquaBeam Robotic System
Robotic system used in Aquablation therapy, a waterjet treatment for BPH.
Commercial
Not stated
Evidence
Company demo only
Medical and surgical
HYDROS Robotic System
AI-powered robotic platform for Aquablation therapy, a waterjet treatment for BPH.
Commercial
Not stated
Evidence
Company demo only
On the map
Sources
11Official filings9
FDA 510(k) clearance K260723: HYDROS Robotic System (HY1000);HYDROS Handpiece (HH1000);HYDROS TRUS Probe (HU1000)
U.S. FDA9 Jul 2026FDA 510(k) clearance K253211: AQUABEAM Robotic System
U.S. FDA23 Jun 2026FDA 510(k) clearance K251082: HYDROS Robotic System (HY1000); HYDROS Handpiece (HH1000); HYDROS TRUS Probe (HU1000)
U.S. FDA10 Oct 2025FDA 510(k) clearance K241952: AQUABEAM Robotic System (AB2000)
U.S. FDA30 Sept 2024FDA 510(k) clearance K240200: HYDROS Robotic System; HYDROS TRUS Probe; HYDROS Handpiece
U.S. FDA20 Aug 2024
4 older official filings
Company claims2
PROCEPT BioRobotics names HYDROS Robotic System on its website.
procept-biorobotics.comUndatedPROCEPT BioRobotics names AquaBeam Robotic System on its website.
procept-biorobotics.comUndated
PROCEPT BioRobotics
2 machines on robomap
